These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 30194296)

  • 1. Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration.
    Paul S; Dansithong W; Figueroa KP; Scoles DR; Pulst SM
    Nat Commun; 2018 Sep; 9(1):3648. PubMed ID: 30194296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A quantitative high-throughput screen identifies compounds that lower expression of the SCA2-and ALS-associated gene ATXN2.
    Scoles DR; Gandelman M; Paul S; Dexheimer T; Dansithong W; Figueroa KP; Pflieger LT; Redlin S; Kales SC; Sun H; Maloney D; Damoiseaux R; Henderson MJ; Simeonov A; Jadhav A; Pulst SM
    J Biol Chem; 2022 Aug; 298(8):102228. PubMed ID: 35787375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of STAU1/staufen1 on autophagy in neurodegenerative diseases.
    Pulst SM; Scoles DR; Paul S
    Autophagy; 2023 Sep; 19(9):2607-2608. PubMed ID: 36652469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staufen Impairs Autophagy in Neurodegeneration.
    Paul S; Dansithong W; Gandelman M; Figueroa KP; Zu T; Ranum LPW; Scoles DR; Pulst SM
    Ann Neurol; 2023 Feb; 93(2):398-416. PubMed ID: 36151701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis.
    Li PP; Sun X; Xia G; Arbez N; Paul S; Zhu S; Peng HB; Ross CA; Koeppen AH; Margolis RL; Pulst SM; Ashizawa T; Rudnicki DD
    Ann Neurol; 2016 Oct; 80(4):600-15. PubMed ID: 27531668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staufen1 in Human Neurodegeneration.
    Paul S; Dansithong W; Figueroa KP; Gandelman M; Scoles DR; Pulst SM
    Ann Neurol; 2021 Jun; 89(6):1114-1128. PubMed ID: 33745139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
    Scoles DR; Dansithong W; Pflieger LT; Paul S; Gandelman M; Figueroa KP; Rigo F; Bennett CF; Pulst SM
    Hum Mol Genet; 2020 Jun; 29(10):1658-1672. PubMed ID: 32307524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
    Sen NE; Canet-Pons J; Halbach MV; Arsovic A; Pilatus U; Chae WH; Kaya ZE; Seidel K; Rollmann E; Mittelbronn M; Meierhofer D; De Zeeuw CI; Bosman LWJ; Gispert S; Auburger G
    Neurobiol Dis; 2019 Dec; 132():104559. PubMed ID: 31376479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
    Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinocerebellar Ataxia Type 2.
    Scoles DR; Pulst SM
    Adv Exp Med Biol; 2018; 1049():175-195. PubMed ID: 29427103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model.
    Dansithong W; Paul S; Figueroa KP; Rinehart MD; Wiest S; Pflieger LT; Scoles DR; Pulst SM
    PLoS Genet; 2015 Apr; 11(4):e1005182. PubMed ID: 25902068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
    Costa RG; Conceição A; Matos CA; Nóbrega C
    Cell Death Dis; 2024 Jun; 15(6):415. PubMed ID: 38877004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stress granule protein G3BP1 alleviates spinocerebellar ataxia-associated deficits.
    Koppenol R; Conceição A; Afonso IT; Afonso-Reis R; Costa RG; Tomé S; Teixeira D; da Silva JP; Côdesso JM; Brito DVC; Mendonça L; Marcelo A; Pereira de Almeida L; Matos CA; Nóbrega C
    Brain; 2023 Jun; 146(6):2346-2363. PubMed ID: 36511898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
    Canet-Pons J; Sen NE; Arsović A; Almaguer-Mederos LE; Halbach MV; Key J; Döring C; Kerksiek A; Picchiarelli G; Cassel R; René F; Dieterlé S; Fuchs NV; König R; Dupuis L; Lütjohann D; Gispert S; Auburger G
    Neurobiol Dis; 2021 May; 152():105289. PubMed ID: 33577922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous ALS and SCA2 associated with an intermediate-length
    Ghahremani Nezhad H; Franklin JP; Alix JJP; Moll T; Pattrick M; Cooper-Knock J; Shanmugarajah P; Beauchamp NJ; Hadjivissiliou M; Paling D; Mcdermott C; Shaw PJ; Jenkins TM
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):579-582. PubMed ID: 33284045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
    Halbach MV; Stehning T; Damrath E; Jendrach M; Şen NE; Başak AN; Auburger G
    PLoS One; 2015; 10(3):e0121089. PubMed ID: 25790475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels.
    Sen NE; Drost J; Gispert S; Torres-Odio S; Damrath E; Klinkenberg M; Hamzeiy H; Akdal G; Güllüoğlu H; Başak AN; Auburger G
    Neurobiol Dis; 2016 Dec; 96():115-126. PubMed ID: 27597528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
    Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
    Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological Studies Support Utility of Positive Modulators of SK Channels for the Treatment of Spinocerebellar Ataxia Type 2.
    Egorova PA; Bezprozvanny IB
    Cerebellum; 2022 Oct; 21(5):742-749. PubMed ID: 34978024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETS1 regulates the expression of ATXN2.
    Scoles DR; Pflieger LT; Thai KK; Hansen ST; Dansithong W; Pulst SM
    Hum Mol Genet; 2012 Dec; 21(23):5048-65. PubMed ID: 22914732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.